高效液相法测定芦荟胶囊中的芦荟甙

 建立了高效液相法测定芦荟胶囊中芦荟甙含量的方法。实验采用ODS柱 ,以甲醇 水 (体积比为 5 0∶5 0 )溶液为流动相 ,用紫外检测器于 2 98nm处检测。结果表明 ,芦荟甙的进样量为 0 0 2 μg～ 1 5 μg时 ,进样量与峰面积呈良好的线性关系 (r =0 9999) ;样品的加标回收率为 99 0 %～ 10 1 9% ;方法的精密度好 ,相对标准偏差(RSD)为 1 37% (n =6 )。方法快速、简便、准确 ,所测结果稳定、重现性好 ,可作为胶囊类保健食品质量检验的一个定量方法。     

Determination of phosphorus in copper-phosphorus alloys,by GLC technique

Summary A simple, sensitive, accurate and rapid gas chromatographic method for the quantitative determination of phosphorus in copper-phosphorus alloys is described. The method is based on the chlorination of the sample with carbon tetrachloride in a sealed glass capsule at 550°C. The volatile products are introduced into the gas chromatograph after crushing the capsule in a special device. The method is very quick (ca. 20 min), involves simple manipulations and the error is about ±0.5%.     

UPLC-ESI-MS法测定贞芪扶正胶囊中毛蕊异黄酮-7-O-β-D-葡萄糖苷、红景天苷和黄芪甲苷的含量

建立了超高效液相色谱-电喷雾串联三重四级杆质谱法(UPLC-ESI-MS)同时测定贞芪扶正胶囊中红景天苷、毛蕊异黄酮-7-O-β-D-葡萄糖苷和黄芪甲苷含量的方法.采用UPLC-ESI-MS联用法,乙腈和0.3%甲酸水溶液不同比例梯度洗脱,流速0.3 m L/min,12 min内可完成测试,且线性关系良好(r20.999).方法简便、准确、可靠、重复性好,可用于贞芪扶正制剂的质量控制.     

Toxicokinetics of strychnine and brucine after the oral administration of Biqi capsule to rats by RRLC–MS/MS

Biqi capsule is a well‐known traditional Chinese medicine formula that has been widely applied for the clinical treatment of such diseases as rheumatoid arthritis, scapulohumeral periarthritis and cervical spondylopathy. However, there is concern regarding the toxicity of Biqi capsule owing to its active ingredients, strychnine and brucine. To investigate the toxicokinetics of strychnine and brucine after oral administration of Biqi capsule to rats, a sensitive and simple rapid‐resolution liquid chromatography/tandem mass spectrometry method was developed to determine the levels of strychnine and brucine in rat plasma. Chromatographic separation was performed on a Capcell Pak C₁₈ MG II (3.0 μm, 2.0 × 35 mm) column by gradient elution with acetonitrile and 0.2% formic acid as the mobile phase. The method was validated over the range of 0.25–250 ng/mL for strychnine and 0.025–25 ng/mL for brucine. The intra‐ and inter‐day accuracies of strychnine and brucine in rat plasma were 100.3–106.6 and 90.75–106.1% respectively, and the precisions were within 14.2%. The established method was successfully applied to the toxicokinetic study of strychnine and brucine after single and multiple oral administration of Biqi capsule to male and female rats at 0.4, 0.8 and 1.6 g/kg doses. The results showed different toxicokinetic characteristics in the different groups.     

Development and validation of a method for determination of caffeine in diuretic tablets and capsules by high-performance thin-layer chromatography on silica gel plates with a concentration zone using manual spotting and ultraviolet absorption densitometry

A new quantitative method using silica gel high-performance thin-layer chromatography plates with channels and a concentration zone, manual application of standards and samples, development with methanol-ethyl acetate (15 + 85) mobile phase, and ultraviolet absorption densitometry is reported for the determination of caffeine in diuretic pharmaceutical preparations. Tablet and capsule products containing potassium salicylate, acetaminophen, and salicylamide as active ingredients were analyzed to test the applicability of the new method, and precision, accuracy, linearity, limits of detection and quantitation, and selectivity were validated. The milligrams of caffeine in each tablet ranged from 48.0 to 51.0, and the milligrams in each capsule from 37.9 to 40.3. Within-day precision was 1.48 and 1.78% (n=6), and interday precision 0.723 and 1.26% (n=5) for analysis of 2 tablets and 2 capsules, respectively. Accuracy validation of the tablet and capsule results produced errors of 1.0 and 1.9% for spiked blank analyses and 2.6 and 3.5% for standard addition analyses, respectively. A comparative study using a caffeine standard solution and a multicomponent analgesic tablet solution containing caffeine, acetaminophen, and acetylsalicylic acid showed that manual application on the concentration zone, instrumental application on the concentration zone, and instrumental application on the silica gel gave quite similar results in terms of number of theoretical plates, resolution, limit of detection, and linearity.     

Ion-Paired Liquid Chromatographic Determination of Cefazolin in Canine Serum and Tissues

Abstract

Cefazolin is commonly used as a prophylactic antibiotic in dogs undergoing total hip arthroplasty.

A sensitive high-performance liquid chromatographic method was developed for the determination of cefazolin in canine serum and tissues. The tissues were those in contact with the hip prothesis; namely, the coxofemoral joint capsule, cancellous bone from the acetabulum and bone marrow from the femoral canal.

The method involved filtration of diluted serum or tissue extracted with ethanol:acetonitrile:water (40:10:50) through a 30,000 molecular weight cut-off filter. Separation of cefazolin from other components was by ion-paired (dodecanosulfonate) high performance liquid chromatography using a reversed-phase column eluted with acetonitrile/water solution. The ultraviolet absorbance of the column effluent was monitored at 230 nm. Recovery of cefazolin spiked at 10 μg/ml from serum was 89.8% with a coefficient of variation (CV) of 5.3% (n=10). Recovery of cefazolin spiked at 5 μg/ml from tissue extracts of joint capsule, cancellous bone and bone marrow was: 93.9%, 98.2%, and 104.2% respectively, with a CV of 6.7%, 10.2% and 10.6% respectively (n=10). A correlation coefficient of 0.9999 occurred with cefazolin in aqueous solution (n=5). The limit of detection for cefazolin was approximately 10 ng/ml of serum or tissue extract.     

HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule

A simple, sensitive and selective high-performance liquid chromatographic (HPLC) method with UV detection (306 nm) was developed and validated for determination of tenatoprazole, a novel proton-pump inhibitor, in dog plasma. Tenatoprazole and internal standard (pantoprazole) were extracted into diethyl ether and separated using an isocratic mobile phase of 10 mm phosphate buffer (pH4.7)-acetonitrile (70:30, v/v) on a Diamonsil C(18) column (150 x 4.6 mm, 5 microm). The retention times for tenatoprazole and internal standard were 7.1 and 12.3 min, respectively. No endogenous interferences were observed. This HPLC method was fully validated. The lower limit of quantitation was 20 ng/mL, with a relative standard deviation of less than 20%. A linear range of 0.02-5.0 microg/mL was established. The interday and intraday precisions were within RSD 13.4-10.1 and 4.6-1.4%, respectively. This method developed can be easily applied to the pharmacokinetic study of tenatoprazole in dog plasma after oral administration of an enteric-coated capsule. The plasma concentration of tenatoprazole from six dogs showed a mean C(max) of 2.63 microg/mL at T(max) of 1.89 h. The bioavailability of tenatoprazole was improved by administration of enteric-coated capsule.     

火焰原子吸收光谱法分析猫爪草胶囊中铁锌锰的含量

为给猫爪草胶囊药用研究提供依据,采用空气-火焰原子吸收光谱法对猫爪草胶囊中铁锌锰元素的含量进行了测定.结果表明,猫爪草胶囊中,铁为287.8 μg/g,锌为27.4 μg/g,锰为24.6 μg/g.方法精密度为2.67%～4.09%,各元素回收率在96.3%～107.6%之间.该法操作简单、结果准确,是猫爪草胶囊中铁...     

Determination of alpha-tocopherol in the Traditional Chinese Medicinal preparation Sea buckthorn oil capsule by non-aqueous reversed phase-HPLC

A non-aqueous reversed phase HPLC was developed for determining alpha-tocopherol in Sea buckthorn oil capsule without the need for saponification. A reversed phase column (Alltima C(18), 4.6 x 250 mm, 5 microm) was used with a mobile phase of methanol-acetonitrile (95 : 5, v/v) and flow rate of 1 ml/min. The contents in capsule were extracted with n-hexane. Detection wavelength was set at 292 nm. Each analysis requires no longer than 20 min. The linearity range for alpha-tocopherol was 9.4-47.0 microg/ml. The detection limit was 0.94 microg/ml. The mean recovery was 95.82 (RSD 2.3%). This method is suitable for quantitative analysis of alpha-tocopherol in Sea buckthorn oil or its Traditional Chinese Medicinal preparation.     

益气通痹胶囊质量标准研究

采用薄层色谱法对益气通痹胶囊中黄芪、何首乌、五味子、赤芍、延胡索进行定性鉴别,采用高效液相色谱法测定了制剂中淫羊藿苷的含量. 所用薄层色谱具有鉴别特征,色谱斑点清晰,专属性强. 淫羊藿苷在0.55~3.30 μg范围内呈良好的线性关系(r =0.99996),平均回收率为98.4%,RSD为0.62 %. 所建立的定性和定量方法,操作简便可靠,专属性强,重现性好,能较全面反映该制剂内在质量,可作为益气通痹胶囊新药研发质量控制标准.     

Marker-based standardization of polyherbal capsule formulation by high-performance thin-layer chromatography (HPTLC)–densitometric method using andrographolide and catechin

Himalaya PartySmart capsule is a polyherbal formulation recommended for its liver-protective properties. As the formulation contains extracts of six different herbs, a large number of markers are present in the same. This research work reports the standardization of Himalaya PartySmart capsule using andrographolide and catechin as therapeutic phytoconstituents to assess its quality and efficacy. A specific, sensitive, precise, and accurate high-performance thin-layer chromatography (HPTLC) method has been developed for the quantitative estimation of andrographolide and catechin. Separation was performed on TLC silica gel 60 F₂₅₄ aluminum plates as the stationary phase using chloroform‒acetone‒formic acid (7:3:0.5, V/V) as the mobile phase with densitometric detection at 259 nm. The developed method was validated as per the recommendations of the International Council for Harmonisation (ICH) Q2(R1) guideline. Each marker phytoconstituent showed a good linear relationship with an average correlation coefficient (r²) = 0.99 in the concentration range studied. The proposed method was found to be specific, precise, and accurate with recovery within the range of 95‒105% and hence can be used for the routine analysis of PartySmart capsule formulation.

     

三维荧光光谱结合二阶校正法测定保健品中的褪黑素

采用三维荧光光谱结合基于交替三线性分解算法(ATLD)的二阶校正方法测定了2种保健品中褪黑素的含量. 当组分数取2时, 测得美益天褪黑素维生素B6胶囊(MYT)和纽斯葆牌褪黑素片(NSB)中褪黑素的含量分别为(3.074±0.019) mg/capsule和(1.649±0.059) mg/tablet, 平均加标回收率分别为(97.9±4.0)%和(103.4±2.7)%, 检出限为1.4 ng/mL. 结果表明, 该方法准确可靠. 该方法具有"二阶优势", 即使样品中存在干扰, 仍可获得较好的结果, 且灵敏度较高. 采用高效液相色谱(HPLC)法对该方法进行了验证, 用t-test对2种方法获得的结果进行比较发现, 2种方法的结果之间无显著性差异, 具有良好的一致性, 但本文方法更环保、 简单. 因此, 三维荧光光谱结合二阶校正方法可作为测定褪黑素含量的新方法, 用于对含褪黑素的保健类产品进行质量监控.     

Liquid chromatography with electrospray ionization mass spectrometry method for the assay of glucosamine sulfate in human plasma: validation and application to a pharmacokinetic study

A liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) method was developed and validated for the assay of glucosamine sulfate in human plasma. Plasma proteins were precipitated by acetonitrile, followed by vortex mixing and centrifugation. The supernatant was transferred and derivatized with phenyl iso-thiocyanate in acetonitrile at 60 degrees C for 40 min. Chromatographic separation was performed on a C(18) column (Inertsil ODS-3 150 x 2.1 mm i.d., 5 microm, JP) with a mobile phase gradient consisting of 0.2% acetic acid (aqueous) and methanol at a flow-rate of 0.3 mL/min. MS detection using electrospray ionization (ESI) as an interface was used in single ion monitoring mode to determine positive ions at m/z 297. This method was shown to be selective and sensitive for glucosamine sulfate. The limit of detection was 35 ng/mL for glucosamine sulfate in plasma and the linear range was 0.1-20 microg/mL in plasma with a correlation coefficient (r) of 0.9991. The relative standard deviations (RSDs) of intra-day and inter-day assays were 8.7-11.4 and 9.8-12.6%, respectively. Extraction recoveries of glucosamine sulfate in plasma were greater than 73%. This method proved to be simple, reproducible and feasible for pharmacokinetic studies of glucosamine sulfate in healthy volunteers after a single oral administration (1500 mg). The pharmacokinetic parameters and relative bioavailabilities were investigated for both domestic glucosamine sulfate tablet and capsule preparations compared with an imported capsule product.     

自动石墨消解–电感耦合等离子体质谱法同时测定左氧氟沙星胶囊中7种金属元素

建立自动石墨消解-电感耦合等离子体质谱法(ICP-MS)同时测定左氧氟沙星胶囊中铅、铬、砷、镉、锡、铝、铁7种金属元素含量的方法。以HNO3-H2O2()体积比为1∶1为消解体系,采用自动石墨消解法消解左氧氟沙星胶囊样品,消解液除酸后,用5%硝酸溶液定容至50 mL,采用电感耦合等离子体质谱法对消解液进行测定,以内标法定量。铅、铬、砷、镉、锡、铝、铁的质量浓度在0.05~20.0μg/mL范围内与质谱响应值成良好的线性关系,相关系数均大于0.998,方法检出限为0.119~1.323μg/kg。样品加标回收率为91.2%~105.5%,测定结果的相对标准偏差为1.67%~3.46%(n=6)。该方法样品前处理简单,检出限低,测定结果准确,适用于左氧氟沙星胶囊等沙星类抗生素中多种金属元素残留的测定。     

Spectrofluorimetric determination of cephradine in commercial formulation using ethylacetoacetate-formaldehyde as fluorogenic agent

A simple, precise and sensitive spectrofluorimetric method was developed for the determination of cephradine in pharmaceutical formulations. The method is based on reaction of cephradine with ethyl acetoacetate (EAA) in the presence of formaldehyde in acidic media. The fluorescence intensity of the resultant fluorescent derivative was measured at 443 nm after excitation at 350 nm. The effects of various experimental parameters on the formation of the fluorescent product were studied and optimized. A linear relationship between concentration of cephradine and fluorescence intensity was found over the range of 0.1–5.0 μg/mL. The limit of detection and quantification were calculated an found 1.09 × 10^?2 ± 3.64 × 10^?3 μg/mL and 3.64 × 10^?2 ± 3.64 × 10^?3 μg/mL, respectively and with relative standard deviation (RSD) 4.14%. Accuracy of the method was checked by standard addition method and applied to four different commercial formulations. The percentage recovery was found in the range of 97.03 to 103.80% for Velora suspension, 98.16 to 102.90% for velocef injection, 99.00 to 108.10% for Velora capsule and 99.06 to 104.90% for Cefradin capsule. The good percentage recoveries from all samples indicated that there were no interferences from the common excipients of formulations. The proposed method was successfully applied to the analysis of commercial suspension, capsule and injections. The result obtained by the proposed method was statistically validated with reference HPLC method. No significant difference in the results of the two methods was found regarding accuracy and precision using Student’s t-test and the variance ratio F-test.     

HPTLC determination of rabeprazole and domperidone in capsules and its validation

This paper describes a validated high-performance thin-layer chromatography (HPTLC) method for simultaneous estimation of rabeprazole (RA) and domperidone (DO) in pure powder and in capsule formulations. An HPTLC method separation is achieved on an aluminum sheet of silica gel 60F(254) using ethyl acetate-methanol-benzene-acetonitrile (30:20:30:20 v/v) as mobile phase. Quantitation is achieved with UV detection at 287 nm over a concentration range of 400-1200 ng/spot and 600-1800 ng/spot with mean recovery of 99.82 +/- 0.74 and 99.43 +/- 0.68 for RA and DO, respectively, in the HPTLC method. This method is simple, precise, and sensitive, and it is applicable for the simultaneous determination of RA and DO in pure powder and in capsule formulation.     

Pulsed amperometric detection (PAD) of diuretic drugs in herbal formulations using a gold electrode following ion-pair chromatographic separation

Herein, we present a new method based on separation by ion-pair chromatography with pulsed amperometric detection for evaluating various diuretics, including hydrochlorothiazide, chlorthalidone, furosemide, and amiloride, which are adulterants in herbal-based pharmaceutical formulations. The amperometric detection cycle (time?=?2 s) was performed at a gold electrode by applying a detection potential (E1) of +800 mV for 0.4 s and an oxidation potential (E2) of +1,000 mV for 0.40 s, followed by a reduction potential (E3) of ?200 mV for 1.20 s. The mobile phase for separating the diuretics was composed of 5 mmol L^?1 phosphate buffer and 0.3 mmol L^?1 sodium dodecyl sulfate in 50 % (v/v) methanol (pH 4.5). This method enabled the quantification of the drugs at low concentrations (i.e., 0.08 mg/capsule for hydrochlorothiazide, 0.01 mg/capsule for chlorthalidone, and 0.007 mg/capsule for furosemide). Twenty-six herbal formulations were analyzed, and eight samples (30.8 %) were found to contain diuretics that were added to the final composition (declared or not).     

Determination of nebivolol and valsartan in a fixed-dose combination by liquid chromatography

An accurate and reproducible liquid chromatographic assay method was developed and validated for the determination of nebivolol and valsartan in a capsule formulation. Buffer-acetonitrile (55 + 45, v/v) was used for reversed-phase liquid chromatography to determine the contents of nebivolol and valsartan in the combination-capsule dosage form. The method was validated by determining parameters such as specificity, linearity, limits of detection and quantitation, precision, accuracy, and robustness. The method was found to be specific against placebo interference. Linearity was evaluated over the concentration ranges of 2-8 micro/mL for nebivolol and 32-128 microg/mL for valsartan (the correlation coefficient was 0.9999 for both nebivolol and valsartan). Both the intraday and interday precision values of the system and the method were determined. The accuracy of the method ranged from 100.66 to 102.58% for nebivolol and from 101.17 to 101.85% for valsartan. The proposed method was found to be robust when slight but deliberate changes were made in the analytical conditions. The developed method was found suitable for the assay determination of nebivolol and valsartan in a capsule formulation.     

Qualitative and quantitative analysis of major constituents from Dazhu Hongjingtian capsule by UPLC/Q‐TOF‐MS/MS combined with UPLC/QQQ‐MS/MS

In this work, a sensitive and efficient method was established and validated for qualitative and quantitative analysis of major bioactive constituents in Dazhu Hongjingtian capsule by liquid chromatography tandem mass spectrometry. A total of 32 compounds were tentatively identified using ultra‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry. Furthermore, 12 constituents, namely gallic acid, 3,4‐dihydroxybenzoic acid, salidroside, p‐ coumaric acid‐4‐O ‐β ‐d ‐glucopyranoside, bergeninum, 4‐hydroxybenzoic acid, 4‐hydroxyphenylacetic acid, syringate, 6′′‐O ‐galloylsalidroside, rhodiosin, rhodionin and kaempferol‐7‐O ‐α ‐l ‐rhamnoside, were simultaneously quantified by the developed ultra‐performance liquid chromatography coupled with a triple quadrupole mass spectrometry method in 9 min. All of them were analyzed on an Agilent ZorBax SB‐C₁₈ column (3.0 × 100 mm, 1.8 μm) with linear gradient elution of methanol–0.1% formic acid water. The proposed method was applied to analyze three batches of samples with acceptable linearity (R , 0.9979–0.9997), precision (RSD, 1.3–4.7%), repeatability (RSD, 1.7–4.9%), stability (RSD, 2.2–4.9%) and recovery (RSD, 0.6–4.4%) of the 12 compounds. As a result, the analytical method possessing high throughput and sensitivity is suitable for the quality control of Dazhu Hongjingtian capsule.     

Development of a potential carrageenan-based hard capsule as the alternative of conventional capsules by implementing the oligomerization reaction

Carrageenan-based (CRG) hard capsules have a slower disintegration rate compared to that of gelatin capsules. Therefore, there is an urgent need to optimize the performance of this material using the oligomerization process. The preparation was conducted by oligomerizing CRG, cross-linking it with maltodextrin (MD), and plasticizing it with sorbitol (SOR). Based on our research, we found that the capsule prepared with the code CRG(O)-MD/SOR had an ash content of 11.80% and a water content of 17.20 ± 1.20 %. No microbes or yeast were found in the capsule, and only negligible amounts of heavy metal traces were present. Scanning electron microscopy (SEM) morphology analysis of the capsule surface showed that no pores were observed, even at a magnification of 10,000 times. This result was supported by the BET-BJH analysis, which showed that the pores had an average diameter of 49.26 Ǻ. Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) showed that the Tg of the prepared capsules was at 51.4 °C. Fourier-transform infrared spectroscopy (FTIR) analysis showed that the presence of citric acid as the oligomerization agent had changed the chain composition of the carrageenan. Acute toxicity analysis showed that the capsule was safe even at a dose of 3,000 mg/bw. The Young's modulus of CRG(O)-MD/SOR was determined to be 1.500 ± 0.52 MPa. In vitro disintegration testing of CRG(O)-MD/SOR showed that the capsule required 20.01 ± 1.13 mins, 23.13 ± 1.14 mins, and more than 120 mins to disintegrate at pH 1.2, 4.5, and 6.8, respectively. Release kinetics analyses showed that the drugs paracetamol (PCT) and salicylamide (SCA) followed the zeroth-order model at pH 1.2 and 4.5, while they were best described by the Peppas-Sahlin model at pH 6.8. Finally, the maximum swelling degree of the CRG(O)-MD/SOR hard capsule was determined to be 708.88%, which was reached in 15.22 mins. This capsule has the potential to be used as an alternative to conventional hard capsules on a broader scale. Furthermore, this work supports Sustainable Development Goals (SDGs) point 3, good health and well-being, by providing a capsule made from biomaterial.